GILEAD SCIENCES, INC. - 10%+ Owner at Xilio Therapeutics, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
XLO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for GILEAD SCIENCES, INC. in Xilio Therapeutics, Inc.

Buys

Open market
Shares
+3,739,000
Avg price
$0.5349
Total value
+$1,999,991

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+3,739,000
Share %
100%
Total value
+$1,999,991

Reported holdings for GILEAD SCIENCES, INC. in Xilio Therapeutics, Inc.

Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Prefunded Warrants (right to buy)
Shares / value
40,384,266
Estimated value
$21,601,543
Report date
13 Feb 2026
Price
$0.5349
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Series A Warrants (right to buy)
Shares / value
13,335,000
Estimated value
Report date
05 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Series C Warrants (right to buy)
Shares / value
13,335,000
Estimated value
Report date
05 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for GILEAD SCIENCES, INC. in Xilio Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .